Privia Health Group Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
PRVA$24.54+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
| For the Three Months Ended September 30, | For the Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenue | $437,921 | $417,282 | $1,275,490 | $1,216,909 |
| Operating expenses: | ||||
| Provider expense | 336,501 | 325,222 | 979,373 | 949,195 |
| Cost of platform | 56,068 | 50,324 | 167,231 | 145,254 |
| Sales and marketing | 7,047 | 7,241 | 19,984 | 18,483 |
| General and administrative | 30,695 | 27,228 | 91,732 | 79,987 |
| Depreciation and amortization | 1,797 | 1,731 | 5,436 | 4,761 |
| Total operating expenses | 432,108 | 411,746 | 1,263,756 | 1,197,680 |
| Operating income | 5,813 | 5,536 | 11,734 | 19,229 |
| Interest income, net | 2,164 | 2,894 | 8,114 | 5,524 |
| Income before provision for income taxes | 7,977 | 8,430 | 19,848 | 24,753 |
| Provision for income taxes | 3,999 | 2,488 | 8,171 | 6,049 |
| Net income | 3,978 | 5,942 | 11,677 | 18,704 |
| Less: Net income (loss) attributable to non-controlling interests | 443 | 299 | 1,691 | (1,537) |
| Net income attributable to Privia Health Group, Inc. | $3,535 | $5,643 | $9,986 | $20,241 |
| Net income per share attributable to Privia Health Group, Inc. stockholders – basic | $0.03 | $0.05 | $0.08 | $0.17 |
| Net income per share attributable to Privia Health Group, Inc. stockholders – diluted | $0.03 | $0.05 | $0.08 | $0.16 |
| Weighted average common shares outstanding – basic | 119,658,574 | 117,602,059 | 119,156,368 | 116,266,938 |
| Weighted average common shares outstanding – diluted | 125,751,006 | 124,924,442 | 125,457,540 | 124,646,849 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.